Cheryl Guttman Krader
Strategies for macular hole recurrence after small-gauge vitrectomy
Findings from a retrospective review provide insights about the outcomes of surgery for recurrent macular holes in the era of small-gauge vitrectomy and possible strategies for reducing their occurrence, said Tarek S. Hassan, MD, at the inaugural Retina World Congress.
Research limited on role of combination therapy for CRVO-related ME
Combination therapy may be a reasonable approach to manage eyes that are not responding to intravitreal monotherapy with an anti-vascular endothelial growth factor (VEGF) agent or corticosteroid, said Lihteh Wu, MD, at the inaugural Retina World Congress.
Treatment for geographic atrophy lacks efficacy in Phase 2 study
In a placebo-controlled, dose-finding, proof-of-concept study conducted in patients with geographic atrophy secondary to age-related macular degeneration, an anti-amyloid β monoclonal antibody (GSK933776, GlaxoSmithKline) was safe and well-tolerated, but did not meet primary or secondary efficacy endpoints.
Findings reaffirm ocriplasmin success for symptomatic VMA over long term
Results of a 2-year phase IIIb study include findings consistent with earlier information about treatment success with ocriplasmin injection for symptomatic vitreomacular adhesion and new information about efficacy and safety over the longer term.
New concepts about macular edema emerge from modern imaging studies
Volume-rendered optical coherence tomography (OCT) imaging allows new insight into retinal vascular flow and morphological changes in eyes with macular edema (ME), and the information obtained is the basis for new ideas about the pathogenesis of ME and therapeutic intervention, according to Richard F. Spaide, MD, Vitreous Retina Macula Consultants of New York.
HPV series completion lags among boys
Findings of a recently published observational retrospective cohort study point to a need for increased efforts to improve timely completion of the human papillomavirus (HPV) vaccine series among boys.
Toric IOL’s transitional conic design enhances tolerance to misalignment
A novel toric IOL features an aberration-free, transitional conic anterior optic surface shows pupil independence and improved tolerance to misalignment in bench testing and excellent clinical outcomes.
Seeing the reality of artificial vision
Seeing the reality of artificial vision
Ophthalmology may be one step closer to the hope of providing artificial vision for individuals affected by virtually all forms of blindness.
Making phaco platform transition increases surgical safety, efficiency
When his surgery center was in the market for a new phacoemulsification platform, medical director Jonathan Solomon, MD, decided to switch from a unit equipped with a flow-based peristaltic pump to technology that features a vacuum-based Venturi system (Stellaris PC, Bausch + Lomb).
New era looming MCC treatment
Immune checkpoint inhibitors are providing rapid and durable responses for patients with metastatic Merkel cell carcinoma.

Poll

View Results